TITLE:
Frequency and Management of Ectopic Pregnancies at the University Hospital Center of Borgou/Alibori (Chud-B/A), Benin, from 2017 to 2022
AUTHORS:
Roger Klikpézo, Mahublo Vinadou Vodouhè, Ingrid Benedicte Olowo, Beaudouin Jean-de-Dieu Edaye, Yèyinou Aurelle Ahouingnan, Eric Dettin, Dagbéssè Elysée Boko Dagoun, Raoul Atadé, Rachidi Sidi Imorou, Awade Afoukou Achille Obossou, Fanny Maryline Nouessèwa Hounkponou Ahouingnan, René Xavier Perrin, Kabibou Salifou
KEYWORDS:
Ectopic Pregnancy, Diagnosis, Therapeutic Management, Prognosis, CHUD-B/A
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.16 No.5,
May
26,
2026
ABSTRACT: Introduction: Ectopic pregnancy (EP) threatens both the functional prognosis (future fertility) and the vital prognosis of the patient. It constitutes a medico-surgical emergency requiring comprehensive emergency obstetric care. Objective: To assess the frequency and management of women diagnosed with ectopic pregnancy at the CHUD-B/A from 2017 to 2022. Methods: This was a descriptive cross-sectional observational study with retrospective data collection conducted at the CHUD-B/A, including all patients managed for ectopic pregnancy from January 1, 2017 to December 31, 2022 (6-year period). Results: Among 13,101 pregnancies managed during the study period, 176 cases of ectopic pregnancy were recorded, yielding a frequency of 1.34% (95% CI: 1.16% - 1.56%); 157 records with complete data were retained for analysis. The mean patient age was 28 ± 5.8 years. The most represented groups were low-parity patients (40.38%), nulliparous women (33.76%), and urban residents (66.24%). Ruptured ectopic pregnancy accounted for 80.25% of cases. The most common anatomical locations were ampullary and isthmic. Management was predominantly surgical via laparotomy, with radical treatment performed in 94.90% of cases. More than half of the patients (61.78%) received blood transfusions, of whom 59.79% underwent autotransfusion. Conclusion: Ectopic pregnancy remains a relatively frequent condition at the CHUD-B/A. This study demonstrated that late diagnosis at the complication stage limits therapeutic options. Autotransfusion represents a viable alternative in the context of blood product shortages.